Latest New Zealand Market News

Solvar Limited has renewed its on-market share buy-back for 12 months, signalling ongoing capital management amid evolving market conditions.

Radius Residential Care has syndicated its bank debt, boosting facility limits by NZD 30 million and cutting financing costs by 65 basis points to support its growth plans, including a new care home acquisition and development projects.

Fletcher Building has cleared a major hurdle in its divestment strategy, with the sale of its Construction Division to VINCI Construction now unconditional and the purchase price rising to about $334 million.

Humm Group reported a 5.1% rise in average assets under management to $5.4 billion in 3Q26, despite lower loan originations and ongoing corporate irregular costs. Credit quality remains stable as the company navigates macroeconomic headwinds and strategic product transitions.

Temple & Webster has delivered its most profitable April ever with EBITDA hitting around $2.5 million, setting the stage for a near doubling of earnings in FY27 despite weak consumer confidence.

Inghams Group has unveiled a comprehensive strategy to stabilise operations, optimise assets, and grow value, reaffirming FY26 EBITDA guidance between $180 million and $200 million amid ongoing cost pressures.

Me Today has raised its full-year revenue forecast to over NZD 7.4 million, driven by strong domestic sales and a new exclusive distribution deal in Southeast Asia. The nutritional supplements company also expects a 25% reduction in EBITDA loss, reflecting tighter cost control amid ongoing product innovation.

MA Financial Group reported a 44% year-on-year jump in assets under management to $14.8 billion in 1Q26, underpinned by strong lending growth and transactional activity despite asset sales and market volatility.

Multistack International Limited (ASX:MSI) has agreed in principle to sell all its assets and liabilities to Hong Kong-based Willing Y Limited, marking a significant strategic shift as MSI plans to discontinue its current business and explore new opportunities.

Channel Infrastructure is partnering with the New Zealand Government to rapidly expand diesel storage capacity at Marsden Point, aiming to strengthen fuel supply resilience within two months.

Algorae Pharmaceuticals has reached a key regulatory milestone as the TGA accepts its initial registration dossier, paving the way for potential commercialisation of its generic medicines in Australia and New Zealand.

Yojee Limited reported a 9% revenue increase driven by software activities, while net losses widened due to accelerated investment in its MOSAIC platform and joint venture costs. The company maintains a robust cash balance and has strengthened its leadership ahead of a mid-2026 commercial launch.